Medical/Pharmaceuticals
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 26, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced that the abstract detailing clinical data from its Australian phase I study of next-generation anti-CTLA-4 antibody in patients with advanced solid tumo...
2021-07-26 19:11
5270
Health and senior care conference held in southwest China's Chongqing Shizhu
CHONGQING, China, July 23, 2021 /PRNewswire/ -- The 5th China Health and Senior Care Conference was heldJuly 19 in Huangshui Town in Shizhu county in southwest China's Chongqing, according to the Publicity Department of Shizhu County. The three-day event focused on traditional Chinese medicine (T...
2021-07-23 18:52
1541
LG SIGNATURE Concludes Charity Auction Benefiting Families Affected by Autism
SEOUL, South Korea, July 22, 2021 /PRNewswire/ -- LG Electronics (LG) has pledged all proceeds from itsSTRONGER TOGETHER charity auction (July 8-18) to Sur les bancs de l'école, a French non-profit organization that has been supporting young people with Autism Spectrum Disorders (ASD) since 2008....
2021-07-23 09:00
8923
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day
SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leading drug development company in the field of brain cancer, today recognizes Glioblastoma (GBM) Awareness Day and calls for a greater focus on research from industry, academia, and government in order ...
2021-07-21 22:00
12186
MedPharm Implements the Peregrine Connect NetSuite PSA Add-in for Microsoft Project to Accurately Forecast Revenue and Cut Manual Labor by 80%
IRVINE, Calif., July 21, 2021 /PRNewswire/ -- Peregrine Connect's NetSuite PSA Add-in for Microsoft Project has been selected by MedPharm to forecast its revenue recognition for ongoing and completed business projects. MedPharm is a world-leading contract development and manufacturing organizati...
2021-07-21 09:00
1253
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by TheUniversity of Tokyo Edge Capital Partners...
2021-07-20 23:00
1904
Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 20, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX:02142) announced the appointment of Dr. Yingying Chen as Chief Financial Officer (CFO). Dr. Chen will be responsible for leading the overall management of Finance & Investor Re...
2021-07-20 21:53
13257
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
* Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND * Samsung Biologics San Francisco R&D center and South Korea headquarters to offer a seamless, end-to-end CDMO service INCHEON, South Korea and SEATTLE, July 20, 2021 /PRNewswire/ -- Sams...
2021-07-20 20:00
2089
Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
HONG KONG, July 20, 2021 /PRNewswire/ -- Novotech Health Holdings Pte. Ltd. ("Novotech") joins a historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The "Decent...
2021-07-20 13:10
1654
Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE
QINGDAO, China, July 19, 2021 /PRNewswire/ -- On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...
2021-07-20 07:15
1648
ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials
SHENZHEN, China, July 18, 2021 /PRNewswire/ -- On July 18, 2021, ImmVira inaugurated a pilot-scale production line inShenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials. Leveraging a strat...
2021-07-19 08:30
2075
Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay
SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...
2021-07-16 14:41
37027
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function
MELBOURNE, Australia, July 15, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced thatMovement Disorders, the official jou...
2021-07-15 21:52
37304
GlobalMed Technologies Launches Home-Use Omnilux Contour™ Light Therapy Products in Australia & New Zealand
FDA-Cleared LED Devices are Based on the Gold Standard Omnilux Medical™ System NAPA, Calif., July 16, 2021 /PRNewswire/ -- GlobalMed Technologies (GMT) announced today that it has launched theOmnilux Contour™ line of home-use LED light therapy products in Australia and New Zealand. Contour produ...
2021-07-15 20:00
1947
iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
WAVRE, Belgium, July 15, 2021 /PRNewswire/ -- iSTAR Medical
2021-07-15 14:00
2344
Kintor Pharmaceutical Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa
SUZHOU, China, July 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. ("Fosun Pharma Development"), on the commercialisation of proxalutamide for the treatment of CO...
2021-07-15 10:00
34552
Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State Government to accelerate the life-sciences hub
- Victorian State Government extends financing of JJIPO@Monash for an additional two years - Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare solutions MELBOURNE, Australia, July 15, 2021 /PRNewswi...
2021-07-15 10:00
1934
Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System
SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization po...
2021-07-14 20:00
31209
Nippon Express Italia Acquires GDP Certification for Company-owned Warehouse near Milan Malpensa Airport
TOKYO, July 14, 2021 /PRNewswire/ -- Nippon Express Italia S.P.A. (hereinafter " NE Italy"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification from the certification body CERTIQUALITY S.r.l., effectiveMay 25, for its company-owned warehouse nea...
2021-07-14 15:00
1821
Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne
SUZHOU, China, July 13, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small-molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug...
2021-07-14 07:05
18433
Week's Top Stories
Most Reposted
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
[Picked up by 321 media titles]
2026-04-09 13:00
Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
[Picked up by 312 media titles]
2026-04-09 09:00Tata Power Collaborates with Databricks to Build Future-Ready Data and AI Platform to Accelerate Energy Transition
[Picked up by 302 media titles]
2026-04-10 11:13
iQIYI to Open Its First Central China Theme Park in Wuhan, Continuing to Bring IP Value Beyond the Screen
[Picked up by 288 media titles]
2026-04-10 11:38
OneQode, Hitachi Vantara & Cylix Form Strategic Alliance to Launch Sovereign AI Factory Initiative
[Picked up by 284 media titles]
2026-04-08 08:00
Most Read
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
2026-04-09 13:00
7614
NYSE Content Update: Starfish Space Adds Over $100 Million in Funding to Boost Growth
2026-04-07 21:06
7394
Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
2026-04-09 09:00
7085